AU-224 is primarily utilized in the field of medical research, particularly in the development of targeted cancer therapies. Its application lies in its ability to selectively bind to specific cancer cell markers, enabling precise delivery of therapeutic agents. This targeted approach minimizes damage to healthy tissues, reducing side effects commonly associated with conventional treatments like chemotherapy. Additionally, AU-224 is being explored for its potential in diagnostic imaging, where it can enhance the visualization of tumors, aiding in early detection and accurate monitoring of disease progression. Its versatility and efficacy make it a promising candidate in advancing precision medicine.